Therapeutic Advances in Psychopharmacology

Papers
(The H4-Index of Therapeutic Advances in Psychopharmacology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness115
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping58
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review51
History repeating: guidelines to address common problems in psychedelic science40
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study31
A rapid clinical response to etifoxine in treatment-resistant obsessive-compulsive disorder: a case report of a patient with comorbid bipolar disorder30
Comment on: History repeating: guidelines to address common problems in psychedelic science29
Readability of informed consent forms from ClinicalTrials.gov in ketamine clinical trials for mental health conditions: a cross-sectional analysis26
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study26
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study26
Adult psychiatrists’ views on clozapine prescribing for schizophrenia in Germany—an online survey23
Psychotropic medications versus non-pharmacologic approaches for managing behavioural and psychological symptoms in Australian aged care residents with dementia: general practitioners’ and physicians’23
Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”21
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search system19
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review18
Sympathetic activation but not dissociation linked to ketamine’s sustained antidepressant effect18
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia17
0.044096946716309